China SXT Pharmaceuticals (SXTC) Other Working Capital Changes (2018 - 2025)
Historic Other Working Capital Changes for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $65057.0.
- China SXT Pharmaceuticals' Other Working Capital Changes fell 6582.06% to $65057.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65057.0, marking a year-over-year decrease of 6582.06%. This contributed to the annual value of $58627.0 for FY2025, which is 6875.98% down from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Other Working Capital Changes is $65057.0, which was down 6582.06% from $58627.0 recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Other Working Capital Changes high stood at $480227.0 for Q3 2021, and its period low was $58627.0 during Q1 2025.
- Over the past 5 years, China SXT Pharmaceuticals' median Other Working Capital Changes value was $134411.0 (recorded in 2022), while the average stood at $194438.2.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Other Working Capital Changes skyrocketed by 35817.07% in 2021, and later tumbled by 7721.68% in 2022.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Other Working Capital Changes stood at $480227.0 in 2021, then tumbled by 77.22% to $109411.0 in 2022, then soared by 33.49% to $146049.0 in 2023, then soared by 30.33% to $190340.0 in 2024, then plummeted by 65.82% to $65057.0 in 2025.
- Its last three reported values are $65057.0 in Q3 2025, $58627.0 for Q1 2025, and $190340.0 during Q3 2024.